The new report titled ‘Global Lymphedema Diagnostics Market published by Emergen Research, is methodically curated by our team of analysts, keeping readers’ understanding in mind, and includes a wide-ranging database of industry distribution. Researchers have taken a holistic approach towards the global market analysis and highlighted the factors that influence the overall growth of the market. The study involves the use of efficient analytical tools like SWOT analysis and Porter’s Five Forces to inspect the strengths, weaknesses, opportunities, and threats associated with the growth of the various market segments.
The global lymphedema diagnostics market size is expected to reach USD 61.9 Million in 2032 and register a steady revenue CAGR of 7.4% during the forecast period, according to latest analysis by Emergen Research. Increasing funding, investments, and grants for lymphedema research is a major factor driving market revenue growth. Lymphedema is a chronic illness generally characterized by swelling in any area of body’s tissues, most notably arms and legs. Lymphedema arises as a result of lymphatic system injury, which can also arise following breast cancer treatment. For instance, on 03 February 2022, Koya Medical, a healthcare organization with the goal of revolutionizing lymphatic and venous treatment through a full range of cutting-edge, customer-focused platforms, announced the conclusion of a USD 26 million Series B funding. Asahi Kasei Ventures, Cadence Healthcare Ventures, and other new investors joined current investors Arboretum Ventures and Scientific Health Development in the round, which was led by 3×5 Partners. In addition, increasing prevalence of chronic diseases, such as cancer and lymphedema, coupled with increasing focus on quality of healthcare is another factor driving revenue growth of the market.
Key Points of Lymphedema Diagnostics Market:
- Extensive coverage of the analysis of the Lymphedema Diagnostics market
- Key insights into the regional spread of the industry in key geographies
- Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
- Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Lymphedema Diagnostics market
- Complete data about the key manufacturers and vendors in the Lymphedema Diagnostics market
Market Drivers:
The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years. The report studies the extensive business expansion plans and advancements in R&D activities and product portfolio. The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.
The report also talks about the shift in demands and emerging trends that are expected to drive the growth of the market. The rising demand for the Lymphedema Diagnostics products is expected to drive the demand for Lymphedema Diagnostics, thereby bolstering the growth of the industry. Moreover, the report also studies the impact of the COVID-19 pandemic on the market.
Browse Full Report Description + Research Methodology + Table of Content @ https://www.emergenresearch.com/industry-report/lymphedema-diagnostics-market
Leading Companies of the Lymphedema Diagnostics Industry and Profiled in the Report are:
GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Hitachi, Ltd., Canon Inc., Shimadzu Corporation, Stryker, Fluoptics, Shanghai United Imaging Healthcare Co., LTD., and ESAOTE SPA
Some Key Highlights From the Report
- On 14 January 2021, according to Koya Medical, a healthcare company that specializes in the treatment of lymphedema and venous disease, a USD 11 million Series A investment round was finalized. Aphelion Capital has joined previous investors Zühlke Ventures, Scientific Health Development Partners, Bolt, and InnerProduct Partners in this round.
- The lymphoscintigraphy segment is expected to account for largest revenue share during the forecast period. This is due to lymphoscintigraphy providing potential for early illness identification owing to its ability to detect molecular activity and lymphoscintigraphy’s non-invasiveness. Lymphoscinitigraphy makes it possible to do a less intrusive operation with fewer side effects and a lower morbidity rate than more invasive surgery, which is also expected to drive market revenue growth .
- The cancer segment is expected to account for significantly large revenue share during the forecast period. This is due to rising prevalence of lymphedema brought on by cancer. For instance, when more lymph nodes and lymph veins are removed or harmed during cancer treatment or biopsies, probability of getting lymphedema increases. Secondary lymphedema is the most serious side effect of breast cancer treatment.
Based on Type, the Lymphedema Diagnostics Market is segmented into:
-
Technology Outlook (Revenue, USD Million; 2019–2032)
- X-ray Lymphography
- Lymphoscintigraphy
- Computed Tomography
- Ultrasound Imaging
- Magnetic Resonance Imaging
- Bioimpedance Analysis
- Near-infrared Fluorescence Imaging
- ICG Lymphography
- Fluorescein Sodium Microlymphangiography
-
Disease Type Outlook (Revenue, USD Million; 2019–2032)
- Cancer
- Cardiovascular Disease
- Inflammatory Diseases
- Others
-
End-Use Outlook (Revenue, USD Million; 2019–2032)
- Hospitals
- Diagnostic Centers
- Research & Academic Institutes
- Others
Regional Analysis:
The report sheds light on the region expected to dominate the Lymphedema Diagnostics market in the coming years. The report estimates the market size in terms of volume and value and offers an accurate estimate of the market share each region is anticipated to hold during the forecast period. The report analyzes the spread of the Lymphedema Diagnostics market in key geographies covering North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The regional analysis offers an idea about the production and consumption pattern, import/export, supply and demand ratio, revenue contribution, market share and size, and the presence of prominent players in each region.
Key Benefits of Buying the Global Lymphedema Diagnostics Report:
- Comprehensive analysis of the changing competitive landscape
- Assists in decision making processes for the businesses along with detailed strategic planning methodologies
- The report offers an 8-year forecast and assessment of the Global Lymphedema Diagnostics market.
- Helps in understanding the key product segments and their estimated growth rate
- In-depth analysis of market drivers, restraints, trends, and opportunities
- Comprehensive regional analysis of the Global Lymphedema Diagnostics Market
- Extensive profiling of the key stakeholders of the business sphere
- Detailed analysis of the factors influencing the growth of the Global Lymphedema Diagnostics Market
Thank you for reading our report. Customization of this report is available in chapter-wise or region-wise sections. Kindly get in touch with us to know more about the report, and our team will provide excellent assistance.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.